BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12722677)

  • 21. Gene therapy insertional mutagenesis insights.
    Davé UP; Jenkins NA; Copeland NG
    Science; 2004 Jan; 303(5656):333. PubMed ID: 14726584
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
    Dropulic B
    Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Good news for gene therapy.
    Berns A
    N Engl J Med; 2004 Apr; 350(16):1679-80. PubMed ID: 15084702
    [No Abstract]   [Full Text] [Related]  

  • 24. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of gene therapy for haematological disorders.
    Nathwani AC; Davidoff AM; Linch DC
    Br J Haematol; 2005 Jan; 128(1):3-17. PubMed ID: 15606545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy of hematologic malignancies.
    Wierda WG; Kipps TJ
    Semin Oncol; 2000 Oct; 27(5):502-11. PubMed ID: 11049018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolution of gene therapy in X-linked severe combined immunodeficiency.
    Rans TS; England R
    Ann Allergy Asthma Immunol; 2009 May; 102(5):357-62; quiz 363-5, 402. PubMed ID: 19492655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
    Kaiser J
    Science; 2003 Jan; 299(5606):495. PubMed ID: 12543948
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene therapy: shining hopes dented - but not dashed.
    Check E
    Nature; 2002 Dec 19-26; 420(6917):735. PubMed ID: 12490910
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulators split on gene therapy as patient shows signs of cancer.
    Check E
    Nature; 2002 Oct; 419(6907):545-6. PubMed ID: 12374936
    [No Abstract]   [Full Text] [Related]  

  • 31. Cancer fears cast doubts on future of gene therapy.
    Check E
    Nature; 2003 Feb; 421(6924):678. PubMed ID: 12610583
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current status of gene therapy in autologous transplantation.
    Becker PS
    Acta Haematol; 2005; 114(4):188-97. PubMed ID: 16269858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
    Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
    Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is retroviral gene marking too dangerous to use?
    Brenner MK; Heslop HE
    Cytotherapy; 2003; 5(3):190-3. PubMed ID: 12850996
    [No Abstract]   [Full Text] [Related]  

  • 38. [Perspectives on postgenome medicine: Hematological diseases].
    Ozawa K
    Nihon Rinsho; 2001 Jan; 59(1):59-64. PubMed ID: 11197862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for lympho-hematopoietic disorders.
    Thrasher AJ; Gaspar HB
    Curr Hematol Rep; 2005 Jul; 4(4):305-9. PubMed ID: 16009046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gene therapy for myeloid leukemia].
    Heike Y
    Nihon Rinsho; 2009 Oct; 67(10):1958-63. PubMed ID: 19860197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.